Knight Therapeutics Inc. (TSE:GUD – Get Free Report)’s stock price reached a new 52-week high on Tuesday . The stock traded as high as C$6.56 and last traded at C$6.56, with a volume of 69474 shares traded. The stock had previously closed at C$6.44.
Knight Therapeutics Trading Up 1.9%
The stock’s fifty day simple moving average is C$6.00 and its 200-day simple moving average is C$6.07. The firm has a market cap of C$651.34 million, a PE ratio of -164.00, a PEG ratio of -1,013.50 and a beta of -0.02. The company has a debt-to-equity ratio of 7.52, a current ratio of 3.36 and a quick ratio of 1.79.
Knight Therapeutics Company Profile
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company’s principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
Read More
- Five stocks we like better than Knight Therapeutics
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Silver $500? The “Deficit Math” says it’s possible.
- Elon Musk: This Could Turn $100 into $100,000
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Knight Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
